What is Geron's stock-based comp?

Geron (GERN) reported stock-based comp of $4.91M in Q1 2026.

How has Geron's stock-based comp changed year-over-year?

Geron's stock-based comp decreased by 33.8% year-over-year, from $7.42M to $4.91M.

What is the long-term trend for Geron's stock-based comp?

Over 4 years (2021 to 2025), Geron's stock-based comp has grown at a 34.8% compound annual growth rate (CAGR), from $8.08M to $26.66M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Geron GERN Stock-Based Comp

Stock-Based Comp at other companies

Bristol-Myers SquibbBMY

$146M+1.4%

IncyteINCY

$64.13M+5.2%

ImmunomeIMNM

$7.95M+39.5%

Syndax PharmaceuticalsSNDX

$12.05M+16.1%

Arcus BiosciencesRCUS

$19M+18.8%

CelcuityCELC

$5.33M+118%

Other financials

Income statement

See full

Revenue$51.8M+30.9%

Operating income$158.0K+101%

Net income-$3.6M+81.6%

EPS (diluted)-$0.01+66.7%

Balance sheet

See full

Cash & equivalents$48.7M-12.2%

Total debt$134.0M+10.0%

Total equity$229.1M-14.6%

Total assets$534.1M-5.0%

Cash flow

See full

Operating cash flow-$62.9M-31.1%

CapEx$206.0K+2.0%

Free cash flow-$43.8M-6.8%

Valuation

See full

Market cap$888.51M-8.6%

Enterprise value$973.78M-6.2%

P/S4.7×-174×

Profitability

See full

Operating margin-705.5%-351pp

Net margin-682.5%-339pp

FCF margin-734.4%-365pp

Returns & leverage

See full

Return on equity-27.1%-7.8pp

Debt / equity0.6×+0.1×

Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Geron's stock-based comp?: Geron (GERN) reported stock-based comp of $4.91M in Q1 2026.
How has Geron's stock-based comp changed year-over-year?: Geron's stock-based comp decreased by 33.8% year-over-year, from $7.42M to $4.91M.
What is the long-term trend for Geron's stock-based comp?: Over 4 years (2021 to 2025), Geron's stock-based comp has grown at a 34.8% compound annual growth rate (CAGR), from $8.08M to $26.66M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.